Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
306.4 USD | -0.05% | -2.02% | +6.30% |
22/05 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
22/05 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.30% | 164B | |
+38.84% | 728B | |
+33.05% | 603B | |
-5.87% | 360B | |
+18.85% | 332B | |
+1.06% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
-0.27% | 122B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Goldman Sachs Starts Amgen at Buy With $258 Price Target